Lisinopril and Hydrochlorothiazide
- Product NDC
- 43353-563
- 11-digit product format
- 433530563
- Labeler code
- 43353
- Product ID
- 43353-563_f79cb952-bc6a-400a-8104-87d8be132302
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA076194
- Marketing category
- ANDA
- Marketing start
- 2003-03-04
- Marketing end
- 0000-00-00
- Substance
- LISINOPRIL; HYDROCHLOROTHIAZIDE
- Active strength
- 20 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| E7199S1YWR | LISINOPRIL | 83915-83-7 | LISINOPRIL |
| 0J48LPH2TH | HYDROCHLOROTHIAZIDE | 58-93-5 | HYDROCHLOROTHIAZIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43353-563-80 | 43353056380 | 180 TABLET in 1 BOTTLE, PLASTIC (43353-563-80) | 180 tablet | 2019-05-08 | 0000-00-00 | No | No | Current |